Entremed (ENMD)

[cycle dude]

The plot thickens....ENMD goes flat @ $3.50 for many moons during the phase 1 healthy trial....The trial is over quickly, NC sez the goals were met...Remember the reformulated slide show?....Celgene stops revlimid drug trial, presents at 3 conferences next week...It'd be a hoot if the reformulated panzem is off the charts, Celgene is loading up,and fixin to put one of thier guys in charge. It's interesting that during the CC, NC stressed emphatically, and more than once, that the property belonged exclusively to ENMD.